Tenax Therapeutics TENX
NASDAQ TENX
$1.76 +0.13 (+7.98%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Raw Materials (2012 - 2014)

Updated

Tenax Therapeutics (TENX) recorded Raw Materials of $28,779 in Q3 2014, unchanged from $28,779 a year earlier and unchanged from the prior quarter.

Analysis

Tenax Therapeutics (TENX) Raw Materials (2012 - 2014) Analysis & Trends

Starting with Q4 2012, Tenax Therapeutics' Raw Materials history includes 8 quarters.

  • Across earlier years, Raw Materials came in at $25,579 in FY2012.
  • Quarterly Raw Materials has ranged from $25,579 in Q4 2012 to $38,147 in Q1 2013 over the past five years.
  • On a year-over-year basis, Raw Materials rose in 1 of the last four quarters, with an average decline of 3.0%.
  • Per Business Quant, the preceding three quarters came in at $28,779 (Q2 2014), $28,779 (Q1 2014) and $28,779 (Q4 2013).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Tenax Therapeutics 91.31 Mn -342.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2014 28,779.00
Oct 31, 2013 28,779.00
Jul 31, 2013 28,779.00
Apr 30, 2013 28,779.00
Jan 31, 2013 28,779.00
Oct 31, 2012 28,779.00
Jul 31, 2012 38,147.00
Apr 30, 2012 25,579.00
API Access

Tenax Therapeutics Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=TENX&period=max&api_key=YOUR_API_KEY